<DOC>
	<DOC>NCT00789360</DOC>
	<brief_summary>The objective of this trial is to assess the pulmonary safety of 2 inhaled doses of Staccato Loxapine within a day.</brief_summary>
	<brief_title>Staccato Loxapine Pulmonary Safety in Healthy Volunteers</brief_title>
	<detailed_description>The planned study is a multiple dose, double-blind, placebo-controlled, randomized, 2-sequence, 2-period crossover study investigating pulmonary safety in healthy volunteers.</detailed_description>
	<mesh_term>Loxapine</mesh_term>
	<criteria>nonsmoker subjects in good general health with normal spirometry at screening AND baseline history of asthma, COPD, or any other acute or chronic pulmonary disease or bronchodilator use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Healthy volunteers</keyword>
</DOC>